New generation aspiration catheter: Feasibility in the treatment of pulmonary embolism

Table 1 Characteristics of 10 patients treated with percutaneous aspiration for pulmonary embolism

Patients	Age (yr)/Sex	Pertinent risk factor	Axial CT RV/LV ratio	Systemic pressure pre therapy (Sys/Dia/HR) (mmHg)	Systemic pressure post therapy (Sys/Dia/HR) (mmHg)	Pulmonary pressure pre therapy (Sys/Dia/Mean) (mmHg)	Pulmonary pressure post therapy (Sys/Dia/Mean) (mmHg)	Concomitant Therapeutics Tpa(mg)/ Heparin Bolus (U)	Death ≤ 30d
Patient 1	67 F	Malignancy, Surgery	1.6	90/66/145	81/65/135	53/37/46	48/31/37	6/6000	Y
Patient 2	74 M	MVA, Surgery	1.7	120/79/133	148/102/122	53/23/33	32/13/19	12/0	N
Patient 3	33 F	Neurosurgery	1.6	100/76/116	94/51/124	54/27/38	11/27/1934	12	Y
Patient 4	47 M	MVA, Surgery	1.3	133/57/143	115/54/131	7/19/1943	4/14/1931	10	Y
Patient 5	47 F	Malignancy, PEs, COPD	0.8	88/65/45	87/52/57	NA/NA/24	NA/NA/10	0	N
Patient 6	57 M	Malignancy	NA	126/102/112	102/79/97	50/35/40	NA	27	Y
Patient 7	64 M	Malignancy, Surgery, COPD	1.3	103/76/115	119/84/90	60/20/40	NA	0	NA
Patient 8	62 M	Diabetes, Hypertension	1.4	111/74/80	104/80/70	58/27/38	44/18/31	16/5000	N
Patient 9	73 M	Malignancy	1.5	116/72/115	116/69/131	NA/NA/30	NA/NA/27	6	Y
Patient 10	63 M	Malignancy	NA	165/82/108	66/57/62	39/15/25	25/14/18	4.5	Y

M: Male; F: Female; COPD: Chronic obstructive pulmonary disease; Dia: Diastolic; HR: Heart Rate; NA: Not available; PEs: Prior pulmonary embolism; RV/LV ratio: Right to left ventricle ratio; Sys: Systolic; tPA: Tissue plasminogen activator; CT: Computed tomography.